(Q34215634)

31 July 2017

A novel peptidomics approach to detect markers of Alzheimer's disease in cerebrospinal fluid (English)

1 reference

31 July 2017

0 references

0 references

Liam A McDonnell

2

0 references

Oleg A. Mayboroda

object named as

Oleg A Mayboroda

8

0 references

Dick Swaab

object named as

Dick F Swaab

6

0 references

Koen Bossers

object named as

Koen Bossers

4

0 references

author name string

Dorien Wijte

1

1 reference

31 July 2017

Crina I A Balog

3

1 reference

31 July 2017

André M Deelder

5

1 reference

31 July 2017

Joost Verhaagen

7

1 reference

31 July 2017

24 March 2012

1 reference

31 July 2017

1 reference

31 July 2017

56

1 reference

31 July 2017

4

1 reference

31 July 2017

500-507

1 reference

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.03.018

A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.03.018

High-resolution serum proteomic profiling of Alzheimer disease samples reveals disease-specific, carrier-protein-bound mass signatures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.03.018

Identification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.03.018

A novel panel of cerebrospinal fluid biomarkers for the differential diagnosis of Alzheimer's disease versus normal aging and frontotemporal dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.03.018

Cerebrospinal fluid biomarkers for Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.03.018

Cerebrospinal fluid biomarkers in the evaluation of Alzheimer disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.03.018

Serial CSF sampling in Alzheimer's disease: specific versus non-specific markers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.03.018

Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.03.018

Integrated analysis of the cerebrospinal fluid peptidome and proteome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.03.018

The MALDI-TOF mass spectrometric view of the plasma proteome and peptidome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.03.018

S100A7, a novel Alzheimer's disease biomarker with non-amyloidogenic alpha-secretase activity acts via selective promotion of ADAM-10

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.03.018

Serum peptide profiling by magnetic particle-assisted, automated sample processing and MALDI-TOF mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.03.018

Reliability of human serum protein profiles generated with C8 magnetic beads assisted MALDI-TOF mass spectrometry.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.03.018

Differential exoprotease activities confer tumor-specific serum peptidome patterns

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.03.018

Comparison of different depletion strategies for improved resolution in proteomic analysis of human serum samples.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.03.018

Immunoaffinity separation of plasma proteins by IgY microbeads: meeting the needs of proteomic sample preparation and analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.03.018

Application of 2-D free-flow electrophoresis/RP-HPLC for proteomic analysis of human plasma depleted of multi high-abundance proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.03.018

A novel approach and protocol for discovering extremely low-abundance proteins in serum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.03.018

Differences among techniques for high-abundant protein depletion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.03.018

Serum peptidome for cancer detection: spinning biologic trash into diagnostic gold

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.03.018

A novel, high-throughput workflow for discovery and identification of serum carrier protein-bound peptide biomarker candidates in ovarian cancer samples

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.03.018

Analysis of albumin-associated peptides and proteins from ovarian cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.03.018

Comparison of beta-protein/A4 deposits and Alz-50-stained cytoskeletal changes in the hypothalamus and adjoining areas of Alzheimer's disease patients: amorphic plaques and cytoskeletal changes occur independently.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.03.018

Neuropathological stageing of Alzheimer-related changes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.03.018

Phosphorylation of human plasma alpha2-Heremans-Schmid glycoprotein (human fetuin) in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.03.018

Peptide repertoire of human cerebrospinal fluid: novel proteolytic fragments of neuroendocrine proteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.03.018

Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.03.018

Concerted changes in transcripts in the prefrontal cortex precede neuropathology in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.03.018

Methods in enzymology: O-glycosylation of proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.03.018

Identification of post-mortem cerebrospinal fluid proteins as potential biomarkers of ischemia and neurodegeneration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.03.018

10.1016/J.YMETH.2012.03.018

7 January 2021

Identifiers

DOI

1 reference

31 July 2017

1 reference